2 Likes
Translating Aging Podcast - Links to the major podcast platforms:
Apple Podcasts:
https://podcasts.apple.com/us/podcast/translating-aging/id1569628505… •
Google Podcasts: https://podcasts.google.com/feed/aHR0cHM6Ly9iaW9hZ2UuY2FwdGl2YXRlLmZtL3Jzc2ZlZWQ… •
Spotify: https://open.spotify.com/show/1AjX0G0C9r1KIaMkB4A9lNNLRP3
1 Like
New on VitaDAO:
One-liner : Cyclarity Therapeutics is an early stage biotechnology company developing computationally designed novel cyclodextrin drug molecules for the extraction of toxic biomolecules that accumulate with age and are implicated in a variety of age-related conditions including cardiovascular disease, macular degeneration, stroke, and liver failure.
They are still at it and this is interesting. I may have to wait for 2028?
2 Likes
Cyclodextrins are interesting! Im glad to see progress is being made with research here.
Is it easier to get through the red tape in Australia? Or are they trying to compete with RemChol? Interesting. Isn’t Cyclarity a US company?
Probably a combination of factors… cheaper (high value of the US dollar right now compared to most currencies), timing / convenience (companies there may be able to move faster and get the study going more quickly and completed more quickly, etc.
Location of the clinical trial has nothing to do with possible competitors.